Future outlook With the pharma building boom showing no signs of slowing down, the future looks bright for the industry…
Browsing: Pharmas
Pharma Companies Struggle to Meet Diversity Goals in Clinical Trials Despite the rhetoric around diversity and inclusion in clinical trials,…
Navigating the Changing Landscape of Drug Pricing and Manufacturing in the Trump Era As the Trump administration continues to implement…
The pharmaceutical industry is undergoing a significant change in leadership, with GSK CEO Emma Walmsley stepping down in favor of…
GLP-1 drugs have already established themselves as a multibillion-dollar market, with companies constantly seeking new opportunities to stay ahead of…
Pharma companies have been engaged in a legal battle against the government’s drug pricing program, known as the Inflation Reduction…
Pharma’s first multi-specific antibody hit the market over a decade ago, paving the way for a surge of interest in…
Basel: A Global Life Sciences Hub Basel, Switzerland, has long been a magnet for life sciences companies, with its stable…
Children with achondroplasia, the most common form of pediatric dwarfism, have historically had limited treatment options. Growth hormones and risky…
